Mobilization of peripheral blood CD34(+) progenitor cells following hydroxyurea therapy in patients with sickle cell disease.

被引：0
|
作者：
Brandt, J [1 ]
Koshy, M [1 ]
Dorn, L [1 ]
Altenhofen, J [1 ]
Hoffman, R [1 ]
机构：
[1] UNIV ILLINOIS,CHICAGO,IL
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：2474 / 2474
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results
    Boulad, Farid
    Shore, Tsiporah
    van Besien, Koen
    Minniti, Caterina
    Barbu-Stevanovic, Mihaela
    Fedus, Sylvie Wiener
    Perna, Fabiana
    Greenberg, June
    Guarneri, Danielle
    Nandi, Vijay
    Mauguen, Audrey
    Yazdanbakhsh, Karina
    Sadelain, Michel
    Shi, Patricia A.
    HAEMATOLOGICA, 2018, 103 (05) : 770 - 777
  • [32] The likelihood of successful allogeneic peripheral blood stem cell (PBSC) mobilization is determined by baseline concentration of CD34(+) cells in blood.
    Brown, RA
    Adkins, DR
    Goodnough, L
    Haug, J
    Todd, G
    DiPersio, J
    BLOOD, 1996, 88 (10) : 1597 - 1597
  • [33] EXPRESSION OF CD143 ON CD34-POSITIVE CELLS IN PERIPHERAL BLOOD AND APHERESIS PRODUCTS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT THE MOBILIZATION OF PERIPHERAL BLOOD PROGENITOR CELLS (PBPCS)
    Kanaeva, M.
    Galtseva, I.
    Davydova, Y.
    Kapranov, N.
    Gaponova, T.
    Mendeleeva, L.
    Parovichnikova, E.
    Savchenko, V.
    HAEMATOLOGICA, 2016, 101 : 637 - 637
  • [34] Flow cytometric characterization of CD34(+) hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients
    DArena, G
    Cascavilla, N
    Musto, P
    Greco, M
    DiMauro, L
    Carella, AM
    DelloIacono, N
    Carotenuto, M
    HAEMATOLOGICA, 1996, 81 (03) : 216 - 223
  • [35] Prior chemotherapy as main factor influencing mobilization of peripheral blood progenitor cells in patients with Hodgkin's disease.
    Canales, MA
    Arrieta, R
    Fernandez, MC
    Alvarez, MT
    Diez, J
    del Pozo, I
    Hernandez, C
    Quevedo, E
    Bustos, JG
    Aguado, MJ
    Ojeda, E
    Hernandez-Navarro, F
    BLOOD, 1999, 94 (10) : 336B - 336B
  • [36] Peripheral blood mononuclear cell gene expression in patients with sickle cell disease.
    Jison, ML
    Munson, PJ
    Schechter, AN
    Barb, J
    Logun, C
    Pease-Fye, M
    Nichols, J
    Danner, RL
    Gladwin, MT
    BLOOD, 2002, 100 (11) : 661A - 662A
  • [37] Prospective study of splenic hypofunction during therapy with hydroxyurea in patients with sickle cell disease.
    Muraca, MF
    Sharma, S
    Gilday, D
    Brown, E
    Nili, N
    Olivieri, F
    BLOOD, 1999, 94 (10) : 415A - 415A
  • [38] Isolation and gene transfer into CD34(+)THY-1(+)LIN cells from peripheral blood of patients with sickle cell anemia.
    Murray, LJ
    Fraser, CC
    Bruno, E
    Kelly, P
    Lubin, B
    Kilpatrick, M
    Conneally, E
    Humphries, RK
    Hoffman, R
    BLOOD, 1995, 86 (10) : 1653 - 1653
  • [39] Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease
    Cangiano, Elisa
    Cavazza, Caterina
    Campo, Gianluca
    Valgimigli, Marco
    Francolini, Gloria
    Malagutti, Patrizia
    Pratola, Claudio
    Ferrari, Roberto
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (01) : 1 - 8
  • [40] Safety and efficacy trial of escalation of plerixafor for mobilization of CD34+Hematopoietic Progenitor Cells (HPCs) and evaluation of globin gene transfer in patients with sickle cell disease. preliminary results
    Boulad, F.
    Shi, P.
    van Besien, K.
    Guarneri, D.
    Greenberg, J.
    Perna, F.
    Judge, A.
    Sadelain, M.
    Tsiporah, S.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S20 - S21
12345